Compare Stocks → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:EUCRNASDAQ:GLAQNASDAQ:MACUNASDAQ:MOTNNYSE:NBA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEUCREucrates Biomedical Acquisition$10.04$10.08$9.87▼$10.25$42.27M-0.072,287 shs12,700 shsGLAQGlobis Acquisition$9.47$9.86$9.10▼$11.00$142.53M-0.0354,887 shs27,176 shsMACUMallard Acquisition$10.09$9.97$9.66▼$10.48$138.74M-0.0676,784 shs1 shsMOTNMotion Acquisition$10.25$10.12$9.77▼$11.86$147.34MN/A89,698 shs879,900 shsNBANew Beginnings Acquisition$9.98$9.27▼$11.00$1.62MN/A112,648 shs2.76 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEUCREucrates Biomedical Acquisition0.00%0.00%0.00%0.00%0.00%GLAQGlobis Acquisition0.00%0.00%0.00%0.00%0.00%MACUMallard Acquisition0.00%0.00%0.00%0.00%0.00%MOTNMotion Acquisition0.00%0.00%0.00%0.00%0.00%NBANew Beginnings Acquisition0.00%0.00%+1.71%-33.53%-78.27%Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full storyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AGLAQGlobis AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AMACUMallard AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AMOTNMotion AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AGLAQGlobis AcquisitionN/AN/AN/AN/AMACUMallard AcquisitionN/AN/AN/AN/AMOTNMotion AcquisitionN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEUCREucrates Biomedical AcquisitionN/AN/A$0.81 per share12.36($1.25) per shareN/AGLAQGlobis AcquisitionN/AN/AN/AN/A($0.23) per shareN/AMACUMallard AcquisitionN/AN/AN/AN/A($1.32) per shareN/AMOTNMotion AcquisitionN/AN/AN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEUCREucrates Biomedical Acquisition$2.42MN/A0.00∞N/AN/A-62.82%2.95%N/AGLAQGlobis Acquisition-$2.67MN/A0.00∞N/AN/A-197.23%-2.87%N/AMACUMallard Acquisition-$3.06MN/A0.00∞N/AN/AN/AN/AN/AMOTNMotion AcquisitionN/AN/A0.0056.94N/AN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/A0.000.00N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEUCREucrates Biomedical AcquisitionN/AN/AN/AN/AN/AGLAQGlobis AcquisitionN/AN/AN/AN/AN/AMACUMallard AcquisitionN/AN/AN/AN/AN/AMOTNMotion AcquisitionN/AN/AN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEUCREucrates Biomedical AcquisitionN/A2.032.03GLAQGlobis AcquisitionN/A0.010.01MACUMallard AcquisitionN/A0.670.67MOTNMotion AcquisitionN/AN/AN/ANBANew Beginnings AcquisitionN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipEUCREucrates Biomedical Acquisition56.02%GLAQGlobis AcquisitionN/AMACUMallard Acquisition79.30%MOTNMotion Acquisition92.40%NBANew Beginnings Acquisition53.03%Insider OwnershipCompanyInsider OwnershipEUCREucrates Biomedical Acquisition19.50%GLAQGlobis AcquisitionN/AMACUMallard Acquisition20.00%MOTNMotion AcquisitionN/ANBANew Beginnings AcquisitionN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableEUCREucrates Biomedical Acquisition44.21 million3.39 millionNot OptionableGLAQGlobis Acquisition115.05 millionN/ANot OptionableMACUMallard Acquisition213.75 million11.00 millionNot OptionableMOTNMotion AcquisitionN/A14.38 millionN/ANot OptionableNBANew Beginnings Acquisition114.38 millionN/ANot OptionableNBA, GLAQ, MOTN, MACU, and EUCR HeadlinesSourceHeadlineLet’s salute Celtics, Bruins while we can … before fans’ playoff angst takes overtheathletic.com - April 19 at 7:00 AMReports: KU earns commitment of transfer wing AJ Storr, one of portal’s top playerswww2.kusports.com - April 18 at 3:59 PMNBA playoffs begin with compelling first-round matchupsamsterdamnews.com - April 18 at 3:59 PMKnicks to face 76ers in first round of NBA playoffs after Philly’s dramatic play-in winnypost.com - April 17 at 11:17 PMJa Morant's injury status, NBA lottery pick highlight Memphis Grizzlies' offseason outlookusatoday.com - April 17 at 8:15 AMNBA futures odds 2024: Top championship predictions, series picks, best bets by proven basketball expertcbssports.com - April 17 at 8:15 AMTrump’s Net Worth Falls Below $4 Billion Again As Truth Social Tanks: Timeline Of His Wealth Whipsawsmsn.com - April 17 at 3:15 AMOakland A’s relocation to bring economic boost to Sacramento areabizjournals.com - April 17 at 3:15 AMNBA history says it's Jayson Tatum's time to make championship leapmsn.com - April 16 at 5:14 PMNBA debuts new 'Playoff Mode' campaign for postseasonsportsbusinessjournal.com - April 16 at 5:14 PMNew York Knicksheavy.com - April 16 at 12:14 PMNBA99: Ranking the 6 best contract values in the NBA this seasonmsn.com - April 16 at 2:12 AMNBA playoffs bracket and play-in tournament schedule live updates: All postseason matchups settheathletic.com - April 15 at 10:34 AM'It's been a long four years': Pacers embracing return to NBA Playoffs at end of droughtmsn.com - April 14 at 11:46 PMSixers end regular season on the right note, beating Nets 107-86phillysportsnetwork.com - April 14 at 6:46 PMNBA Rumors: Nets GM Sean Marks to Return Despite Struggles, Will Lead HC Searchbleacherreport.com - April 14 at 6:46 PMWhat Will a Paramount Controlled By Republican Mega-Donor Larry Ellison Look Like?nexttv.com - April 14 at 6:46 PMKnicks playoff picture: Breaking down New York's seeding scenarios in 2024 NBA bracketsportingnews.com - April 12 at 1:57 PMEvery NBA team's most pleasant surprise in 2023-24: Lakers' D'Angelo Russell, young Warriors among eye-openerscbssports.com - April 12 at 1:57 PM3 early Wizards NBA free agency targets in 2024 offseasonmsn.com - April 11 at 3:47 PMFrist's Yoshi Mobility raises $26 million for expansionbizjournals.com - April 11 at 8:36 AMNBA rumors: NBA GM slams Bronny James, Celtics' Jrue Holiday risk, OG Anunoby asking pricemsn.com - April 10 at 8:12 PMSBJ Morning Buzz: NBA Board of Governors meetings to hit on media deal, Minnesota Timberwolvessportsbusinessjournal.com - April 10 at 3:12 PM3 early Hornets NBA free agency targets in 2024 offseasonmsn.com - April 10 at 3:12 PMNew MarketBeat Followers Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains Imminent5 Stocks in the Current Bull Market with Upside to ComeApril 5, 2024 10:14 AMView 5 Stocks in the Current Bull Market with Upside to ComeBreakout Alert: Coinbase's Consolidation Is About To EndApril 12, 2024 9:45 AMView Breakout Alert: Coinbase's Consolidation Is About To EndAll In: Is MicroStrategy Overleveraging Its Future on Bitcoin? March 26, 2024 6:05 AMView All In: Is MicroStrategy Overleveraging Its Future on Bitcoin? All Headlines Company DescriptionsEucrates Biomedical AcquisitionNASDAQ:EUCREucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.Globis AcquisitionNASDAQ:GLAQGlobis Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Boca Raton, Florida.Mallard AcquisitionNASDAQ:MACUMallard Acquisition Corp. does not have significant operations. It focuses on the effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Cornelius, North Carolina.Motion AcquisitionNASDAQ:MOTNMotion Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company intends to focus on the vehicle industry, which includes companies that provide transportation software and cloud solutions for fleet management, freight and logistics, and mobile asset management applications. Motion Acquisition Corp. was incorporated in 2020 and is based in New York, New York.New Beginnings AcquisitionNYSE:NBANew Beginnings Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Miami, Florida. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.